Clinical Trial

Spotting Syphilis: A Dual Point-of-Care Syphilis Screening Initiative in a Low-Resource Healthcare Setting

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine if a strategy utilizing the Chembio HIV/syphilis rapid point-of-care (POC) test for diagnosis of HIV and syphilis in pregnant women attending prenatal clinics in Guatemala will increase screening and detection rates thereby resulting in higher rates of treatment during pregnancy and ultimately reducing congenital syphilis and HIV Mother-to-child transmission (MTCT) and to provide knowledge and technical expertise on the use of Point-of-care ultrasound for all pregnant patients testing positive for syphilis during the intervention to evaluate the fetus for evidence of congenital syphilis.
Trial Details
NCT Number NCT07498153
Lead Sponsor The University of Texas Health Science Center, Houston
Conditions Syphilis, HIV Infections
Enrollment 149 participants
Start Date 2025-09-30
Primary Completion 2025-10-02 (estimated)
Study Completion 2025-10-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-27